Jan 30 |
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."
|
Jan 4 |
DSS chairman Chan acquires 672,173 shares in open market; shares jump
|
Jan 4 |
DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market
|
Jan 2 |
DSS director Heng Fai Ambrose purchases about 672K shares
|
Dec 26 |
DSS announces 1-for-20 reverse stock split to regain NYSE American compliance
|
Dec 22 |
DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan
|
Nov 28 |
DSS: Q3 2023 Results Show Hesitation from DSS Customers Due to A Worsening Economy and Government Inaction
|
Nov 28 |
DSS jumps after its subsidiary secures contract extension worth up to $15M over four years
|
Nov 28 |
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years
|
Nov 15 |
Impact Biomedical Inc. Files Current Report on Form 8-K
|